Valuation Unichem Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:10 2026-07-09 EDT			5-day change	1st Jan Change
650.60 ^INR	+13.60%		+37.10%	+47.24%

05-22	Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-22	Unichem Laboratories March-quarter consol profit 109.1 million rupees	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	21,776	18,330	20,351	34,393	48,777	20,682
Change	-	-15.83%	11.02%	69%	41.82%	-57.6%
Enterprise Value (EV) ¹	19,829	18,094	21,638	35,346	52,479	22,788
Change	-	-8.75%	19.59%	63.35%	48.47%	-56.58%
P/E	63.4x	55.6x	-10.1x	-48.8x	35.6x	8.19x
PBR	0.85x	0.7x	0.84x	1.46x	1.99x	0.76x
PEG	-	-13.88x	0x	0.7x	-0x	0.1x
Capitalization / Revenue	1.76x	1.44x	1.52x	2.02x	2.31x	0.94x
EV / Revenue	1.61x	1.42x	1.61x	2.07x	2.49x	1.03x
EV / EBITDA	23.6x	24.2x	-45.1x	37.5x	20.4x	12.6x
EV / EBIT	273x	-166x	-13.9x	-272x	37.4x	35.8x
EV / FCF	-9.72x	-5.18x	-29.2x	64.1x	-23.3x	-20.8x
FCF Yield	-10.3%	-19.3%	-3.42%	1.56%	-4.3%	-4.8%
Dividend per Share ²	4	4	-	-	-	-
Rate of return	1.29%	1.54%	-	-	-	-
EPS ²	4.875	4.68	-28.72	-10.01	19.47	35.85
Distribution rate	82%	85.5%	-	-	-	-
Net sales ¹	12,351	12,698	13,430	17,049	21,110	22,018
EBITDA ¹	838.6	747	-480.2	943.7	2,577	1,815
EBIT ¹	72.76	-109	-1,556	-129.9	1,403	635.7
Net income ¹	343.2	330.6	-2,022	-704.7	1,375	2,528
Net Debt ¹	-1,948	-236.2	1,288	952.6	3,702	2,107
Reference price ²	309.30	260.35	289.05	488.50	692.80	293.75
Nbr of stocks (in thousands)	70,406	70,406	70,406	70,406	70,406	70,406
Announcement Date	7/2/21	7/12/22	8/30/23	7/11/24	7/4/25	7/3/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	330B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
Average	16.38x	6.59x	16.89x	2.39%	406.65B
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%